Lv4
486 积分 2023-11-01 加入
Plozasiran, an RNA Interference Agent Targeting APOC3, for Mixed Hyperlipidemia
1天前
已完结
Plozasiran for Managing Persistent Chylomicronemia and Pancreatitis Risk
1天前
已完结
Effects of bimagrumab, an activin receptor type II inhibitor, on pituitary neurohormonal axes
4天前
已完结
Bimagrumab improves body composition and insulin sensitivity in insulin‐resistant individuals
4天前
已完结
The GIP receptor activates futile calcium cycling in white adipose tissue to increase energy expenditure and drive weight loss in mice
19天前
已完结
Is Weight Loss–Induced Muscle Mass Loss Clinically Relevant?
22天前
已完结
Muscle matters: the effects of medically induced weight loss on skeletal muscle
22天前
已完结
Sequencing of 640,000 exomes identifies GPR75 variants associated with protection from obesity
22天前
已完结
Dozens of new obesity drugs are coming: these are the ones to watch
23天前
已完结
Sweeping antibody as a novel therapeutic antibody modality capable of eliminating soluble antigens from circulation
23天前
已完结
皖公网安备34019202002308
